CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 8,333 shares at an average $36.18 ($301,451)
- 4 Open-market sale President and CEO sold 20,000 shares at an average $38.79 ($775,860)
- 4 Open-market sale President and CEO sold 3,338 shares at $35.28 ($117,765)
- 4 Open-market sale President and CEO sold 14,995 shares at an average $34.15 ($512,053)
- 4 Open-market sale Chief Financial Officer sold 14,649 shares at an average $24.68 ($361,465)
- 4 Open-market sale President and CEO sold 8,333 shares at an average $29.58 ($246,522)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $25.08 ($250,805)
- 4 Open-market sale President and CEO sold 8,333 shares at an average $23.64 ($196,966)
- 4 Open-market sale President and CEO sold 8,333 shares at an average $24.78 ($206,525)
- 4 Open-market sale President and CEO sold 16,666 shares at an average $20.33 ($338,831)
- 4 Other acquisition Director acquired 1,686 shares (other)
- 4 Open-market sale President and CEO sold 16,666 shares at an average $20.02 ($333,610)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 18 · 351 filings